| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 16,364,000 | 15,703,000 | 16,210,000 | 16,475,000 | | Cost of Revenue | 11,826,000 | 11,357,000 | 11,751,000 | 11,818,000 | | | Gross Profit | 4,538,000 | 4,346,000 | 4,459,000 | 4,657,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,741,000 | 3,644,000 | 3,613,000 | 3,627,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 797,000 | 702,000 | 846,000 | 1,030,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 776,000 | 702,000 | 846,000 | 1,030,000 | | Interest Expense |
-
| 23,000 | 25,000 | 20,000 | | Income Before Tax | 776,000 | 679,000 | 821,000 | 1,010,000 | | Income Tax Expense | 287,000 | 243,000 | 299,000 | 370,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 489,000 | 436,000 | 522,000 | 640,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 489,000 | 436,000 | 522,000 | 640,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $489,000 | $436,000 | $522,000 | $640,000 |
|
0.43% Nasdaq 
Income Statement
